首页> 外国专利> PROLIFERATION INHIBITOR OF POOR-PROGNOSIS CANCER CELLS

PROLIFERATION INHIBITOR OF POOR-PROGNOSIS CANCER CELLS

机译:不良预后癌细胞的增殖抑制剂

摘要

The present inventor found that, in a cancer disease, cancer cells showing a large expression amount (production amount) of fibrillarin are associated with poor prognosis (a low survival rate). Also, the present inventor found that the proliferation of cancer cells can be inhibited by reducing the expression amount (production amount) of fibrillarin. As a result, it becomes possible to inhibit the proliferation of poor-prognosis cancer cells to thereby treat a cancer disease by using the inhibitor of the expression or activity of fibrillarin according to the present invention. Typical examples of the inhibitor of the expression or activity of fibrillarin include an siRNA, an shRNA, an antisense, etc.
机译:本发明人发现,在癌症疾病中,原纤维蛋白表达量大(产生量大)的癌细胞预后不良(存活率低)。另外,本发明人发现可以通过减少原纤维蛋白的表达量(产生量)来抑制癌细胞的增殖。结果,通过使用根据本发明的原纤维蛋白的表达或活性抑制剂,可以抑制预后差的癌细胞的增殖从而治疗癌症。抑制原纤维蛋白表达或活性的抑制剂的典型例子包括siRNA,shRNA,反义等。

著录项

  • 公开/公告号WO2020071392A1

    专利类型

  • 公开/公告日2020-04-09

    原文格式PDF

  • 申请/专利权人 ER STRESS RESEARCH INSTITUTE INC.;

    申请/专利号WO2019JP38825

  • 发明设计人 OYADOMARI SEIICHI;

    申请日2019-10-01

  • 分类号A61K45;A61K31/713;A61K38/08;A61K48;A61P1;A61P11;A61P13/12;A61P15;A61P25;A61P35;A61P43;

  • 国家 WO

  • 入库时间 2022-08-21 11:12:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号